Insider Transactions in Q3 2023 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,000
-2.39%
|
$56,000
$28.58 P/Share
|
|
Sep 18
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,427
-2.59%
|
$44,237
$31.31 P/Share
|
|
Sep 18
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,214
-2.81%
|
$37,634
$31.31 P/Share
|
|
Sep 18
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
8,054
-2.25%
|
$249,674
$31.31 P/Share
|
|
Sep 18
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,060
-0.7%
|
$63,860
$31.31 P/Share
|
|
Sep 18
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,514
-2.53%
|
$77,934
$31.31 P/Share
|
|
Sep 15
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.79%
|
$160,000
$32.08 P/Share
|
|
Sep 15
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.57%
|
$20,000
$4.09 P/Share
|
|
Sep 01
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
10,000
-12.37%
|
$350,000
$35.04 P/Share
|
|
Sep 01
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
30,000
-7.74%
|
$1,050,000
$35.05 P/Share
|
|
Sep 01
2023
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+3.79%
|
$0
$0.83 P/Share
|
|
Sep 01
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-26.63%
|
$700,000
$35.05 P/Share
|
|
Sep 01
2023
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+21.03%
|
$40,000
$2.68 P/Share
|
|
Sep 01
2023
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
15,000
-48.66%
|
$525,000
$35.07 P/Share
|
|
Sep 01
2023
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.47%
|
$30,000
$2.93 P/Share
|
|
Aug 31
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.13%
|
$340,000
$34.05 P/Share
|
|
Aug 31
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.37%
|
$40,000
$4.09 P/Share
|
|
Aug 15
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.42%
|
$150,000
$30.58 P/Share
|
|
Aug 15
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.57%
|
$20,000
$4.09 P/Share
|
|
Aug 02
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,666
-5.39%
|
$533,312
$32.4 P/Share
|
|
Aug 01
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,666
-5.12%
|
$483,314
$29.19 P/Share
|
|
Jul 31
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-3.35%
|
$39,000
$26.02 P/Share
|